PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11985335-1	2001	The primary metabolic pathways of caffeine are 3-N-demethylation to paraxanthine (CYP1A2), 1-N-demethylation to theobromine and 7-N-demethylation to theophylline (CYP1A2 and other enzymes), and 8-hydroxylation to 1,3,7-trimethyluric acid (CYP3A).	Caffeine	34-42	cytochrome P450, family 1, subfamily a, polypeptide 2	Rattus norvegicus	82-88	
11985335-1	2001	The primary metabolic pathways of caffeine are 3-N-demethylation to paraxanthine (CYP1A2), 1-N-demethylation to theobromine and 7-N-demethylation to theophylline (CYP1A2 and other enzymes), and 8-hydroxylation to 1,3,7-trimethyluric acid (CYP3A).	Caffeine	34-42	cytochrome P450, family 1, subfamily a, polypeptide 2	Rattus norvegicus	163-169	
11985335-1	2001	The primary metabolic pathways of caffeine are 3-N-demethylation to paraxanthine (CYP1A2), 1-N-demethylation to theobromine and 7-N-demethylation to theophylline (CYP1A2 and other enzymes), and 8-hydroxylation to 1,3,7-trimethyluric acid (CYP3A).	Caffeine	34-42	cytochrome P450, family 3, subfamily a, polypeptide 62	Rattus norvegicus	239-244	
11985335-1	2001	The primary metabolic pathways of caffeine are 3-N-demethylation to paraxanthine (CYP1A2), 1-N-demethylation to theobromine and 7-N-demethylation to theophylline (CYP1A2 and other enzymes), and 8-hydroxylation to 1,3,7-trimethyluric acid (CYP3A).	Theophylline	149-161	cytochrome P450, family 1, subfamily a, polypeptide 2	Rattus norvegicus	163-169	
11985335-1	2001	The primary metabolic pathways of caffeine are 3-N-demethylation to paraxanthine (CYP1A2), 1-N-demethylation to theobromine and 7-N-demethylation to theophylline (CYP1A2 and other enzymes), and 8-hydroxylation to 1,3,7-trimethyluric acid (CYP3A).	1,3,7-trimethyluric acid	213-237	cytochrome P450, family 1, subfamily a, polypeptide 2	Rattus norvegicus	163-169	
11985335-9	2001	The isoenzymes CYP1A2 and CYP3A2 were distinctly inhibited by all the investigated neuroleptics, while other CYP isoenzymes (CYP2B and/or 2E1) by perazine and levomepromazine.	Perazine	146-154	cytochrome P450, family 1, subfamily a, polypeptide 2	Rattus norvegicus	15-21	
11985335-9	2001	The isoenzymes CYP1A2 and CYP3A2 were distinctly inhibited by all the investigated neuroleptics, while other CYP isoenzymes (CYP2B and/or 2E1) by perazine and levomepromazine.	Perazine	146-154	cytochrome P450, family 3, subfamily a, polypeptide 2	Rattus norvegicus	26-32	
11985335-9	2001	The isoenzymes CYP1A2 and CYP3A2 were distinctly inhibited by all the investigated neuroleptics, while other CYP isoenzymes (CYP2B and/or 2E1) by perazine and levomepromazine.	Methotrimeprazine	159-174	cytochrome P450, family 1, subfamily a, polypeptide 2	Rattus norvegicus	15-21	
11985335-9	2001	The isoenzymes CYP1A2 and CYP3A2 were distinctly inhibited by all the investigated neuroleptics, while other CYP isoenzymes (CYP2B and/or 2E1) by perazine and levomepromazine.	Methotrimeprazine	159-174	cytochrome P450, family 3, subfamily a, polypeptide 2	Rattus norvegicus	26-32